May 4, 2026
1 min read

FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib MedNews

MONDAY, May 4, 2026 The U.S. Food and Drug Administration (FDA) granted expanded access for the use of an experimental pancreatic cancer drug, daraxonrasib.This

Leave a Reply

Your email address will not be published.

Previous Story

Supreme Court restores access to abortion pill mifepristone through telehealth, mail, and pharmacies

Next Story

Prolific Machines sets monoclonal antibody manufacturing record with light-controlled platform

Previous Story

Supreme Court restores access to abortion pill mifepristone through telehealth, mail, and pharmacies

Next Story

Prolific Machines sets monoclonal antibody manufacturing record with light-controlled platform

Latest from Blog

Go toTop